|
|
Volumn 19, Issue 2, 2002, Pages 105-108
|
|
VAD followed by VMCP: An alternative regimen for multiple myeloma
a
|
|
Author keywords
Chemotherapy; Multiple myeloma; Response rate; Sequential; Survival
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
DOXORUBICIN;
MELPHALAN;
PREDNISOLONE;
VINCRISTINE;
ANTINEOPLASTIC AGENT;
VAD PROTOCOL;
VCSP PROTOCOL;
ADULT;
AGED;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER REGRESSION;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
DRUG EFFICACY;
FEMALE;
HUMAN;
INTERMETHOD COMPARISON;
MALE;
MULTIPLE MYELOMA;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
CLINICAL TRIAL;
DISEASE FREE SURVIVAL;
DRUG ADMINISTRATION;
INDIA;
MIDDLE AGED;
MORTALITY;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
DISEASE-FREE SURVIVAL;
DOXORUBICIN;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
HUMAN;
INDIA;
MALE;
MELPHALAN;
MIDDLE AGE;
MULTIPLE MYELOMA;
PREDNISOLONE;
VINCRISTINE;
HUMANS;
MIDDLE AGED;
|
|
EID: 0036017508
PISSN: 13570560
EISSN: None
Source Type: Journal
DOI: 10.1385/MO:19:2:105 Document Type: Article |
|
Times cited : (3)
|
|
References (7)
|
